Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acetaminophen Market

Acetaminophen Market Share

Report ID: GMI5935
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Acetaminophen Market Share

Major market players operating in the acetaminophen market include

Sanofi
Janssen Pharmaceuticals
Pfizer Inc.
Bayer AG
Glaxo SmithKline Pharmaceuticals Ltd
Granules India Limited
Alkem Laboratories Ltd
Abbott
Lupin Ltd
Teva Pharmaceuticals USA, Inc.
BRISTOL-MYERS SQUIBB
B.BRAUN MELSUNGEN
Novartis AG
IOL Chemicals and Pharmaceuticals
Sun Pharmaceutical Industries Limited
Aurobindo Pharma
Hyloris Pharmaceuticals SA
Dr. Reddy's Laboratories Ltd.
Mallinckrodt (Mallinckrodt Pharmaceuticals)

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Acetaminophen market size was USD 9.8 billion in 2022 and will record over 4.8% CAGR between 2023 to 2032.

The parenteral route of administration segment will reach around USD 1.3 billion by the end of 2032 as it offers direct and rapid delivery of the drug into the bloodstream.

North America holds the largest regional share in acetaminophen market due to the presence of key players, high incidence of fever, headaches, migraine, and a well-structured healthcare system.

BRISTOL-MYERS SQUIBB, Bayer AG, Sun Pharmaceutical Industries Limited, Glaxo SmithKline Pharmaceuticals Ltd, Alkem Laboratories Ltd, Abbott, B.BRAUN MELSUNGEN, Novartis AG, IOL Chemicals and Pharmaceuticals, Lupin Ltd, and Teva Pharmaceuticals USA, Inc.